Introduction
Since Adams and Imagawa (1962) first reported a slightly increased average titre of antibody against measles virus in the serum of patients with multiple sclerosis (M.S.) many workers, using a variety of different techniques, have confirmed this finding (Brody et al., 1972) . In a few studies a higher prevalence of antibody to measles virus has been deteoted in cerebrospinal fluids (C.S.F.) from patients with M.S. compared with patients with other neurological diseases. Using the sensitive mixed haemadsorbing antibody technique Brown et al. (1971) found 79% of 119 patients with M.S. had measles antibody in C.S.F. compared with 45% of a control group of 112 patients with other neurological diseases, while Salmi et al. (1974) found increased incidence of antibodies against three structural components of measles virus compared with controls.
The frequency of relatively increased IgG in the C.S.F. (Link and Miller, 1971) and the demonstration in the C.S.F. of a few patients with M.S. of IgG which contained measles antibody (Salmi et al., 1972; Panelius and Salmi, 1973) encouraged us to examine a larger number of C.S.F.s from MS. patients for virus-specific IgG antibody. Though we have found IgG antibody specific for several viruses in the C.S.F. of M.S. patients measles virus-specific IgG has predominated , and in separate studies the prevalence has been consistent (table I) .
We now present the findings of a further study in which we examined the effect of concentration of C.S.F. on the prevalence and t1,res of measles virus-specific IgG antibody.
Patients and Methods C.S.F. was obtained from 31 patients with M.S., 29 patients suffering from other well-defined neurological diseases, and 15 patients undergoing myelography for suspected prolapsed intervertebral disc. The last group formed our "normal' control group. In the neurological control group there were four cases of motor neurone disease, three of neurosyphilis, three of dementia, three of polyneuropathy, three of' secondary carcinomata, two of Chiari syndrome, two of syringomyelia, two of spondylosis, two of myelitis, and one of each of the following: Friedrich's ataxia, epilepsy, cerebrovascular disease, diabetic amyotrophy, and pseudobulbar palsy. The fluids were from consecutive patients from whom sufficient was available for concentration.
Specimens were stored at -20'C and were thawed once for concentration, by means of an Amicon 8-MC ultrafiltration unit with a PM-30 membrane. Each specimen was concentrated fivefold and an aliquot of the orginal material was retained for testing. Samples were refrozen and were finally tested in large experiments under standard conditions. They were examined by means of the indirect immunofluorescent technique for measles virus-specific IgG using acetone-fixed virus-infected HEp, cells as antigen, as previously described (Haire and Hadden, 1970; Millar et al., 1971; . These assessments were made without knowledge of the patient's group.
To determine if measles virus-specific IgG antiibody was associated with either the age or sex of the patient a study was made of the titres of measles IgG in serum from normal healthy adults, 46 men and 45 women.
Results Though the M.S. patients and the normal control subjects were of similar average age the neurological control patients were on average significantly (at P <0 05, used throughout this report) older than either of the two other groups ( Bfore concentration the percentage of C.S.F.s with detectable measles IgG in the MS. group (58 1%) significantly exceeded that in either.the neurological control group (24-1%) or normal control group (0%). The difference between the two control groups just failed to reach significance at the 5% level (P = 0 0765). After concentration the percentage of C.S.F.s with detectable measles IgG in the M.S. group (80 6%) significantly exceeded that of the neurological control group (345%), which in turn significantly exceeded that in the normal control group (0%). The increase in the prevalence of measles IgG in the C.S.F. of M.S. patients after concentration was significantly more than would have been expected by chance (P = 0016). A similar, but much less marked, trend occurred in the neurological contol group (P = 0-25).
Discussion
While other workers have found higher levels of measles antibody in women than in men in groups of M.S. patients, in cheir siblings, and in normal control people resident in the same area (Henson et al., 1970; Salmi et al., 1973) , we did not show a sex difference of measles IgG in the serum of normal controls. Though the numbers in our study groups were small we feel that the differences in average age between our three groups of subjects did not invalidate our results.
We report now a prevalence of measles IgG in the C.S.F. of patients with M.S. of 58-1%, a rate consistent with our previous findings (see table 1 ). In this study, however, the prevalence of measles IgG in the C.S.F. of patients with other neurological diseases was higher than we found before, 241 % compared with 6&7% . We cannot offer an explanation but because of the small numbers the possibility that this is a chance difference cannot be overlooked. The diagnoses in the group were rather similar to those in our earlier study b) and we did not have a "concentrate" of patients with one clinical condiction.
The significantly high increase in prevalence of measles IgG in the C.S.F. of M.S. patients as a result of the fivefold concentration compared with a lower rate of increase in the neurological control group may result from a qualitative difference between the immunoglobulins in the fluids. This may be due to the oligoclonal pattern of the IgG in the C.S.F. of the M.S. patients (Link and Muller, 1971) . Panelius and Salmi (1973) 
